FRACR Christopher S Hamilton BMedSci
Research Subjects
FRACR Christopher S Hamilton BMedSci has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
A Hindley
Lancashire and Lakeland Radiotherapy Unit, Royal Preston Hospital, Fullwood, Preston, UK
1 shared publicationA Steigler
Department of Radiation Oncology, Newcastle Mater Misericordiae Hospital, New South Wales
1 shared publicationD Lamb
Department of Radiation Oncology, Wellington Hospital, Wellington, New Zealand
1 shared publicationH Krawitz
Auckland Hospital, Auckland, New Zealand
1 shared publication- James William Denham
School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
1 shared publication L Peters
Peter MacCallum Institute, Melbourne, Victoria, Australia and
1 shared publication
Latest Publications
- 1 May 1999
- Published by Wiley in Australasian Radiology
- Vol. 43 (2) , 227-232
Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01)
The Trans‐Tasman Radiation Oncology Group (TROG) initiated a randomized trial, testing accelerated (twice daily) radiotherapy against conventional radiotherapy for stage III and stage IV squamous cell carcinoma of the head and neck in 1991. In 1996, the Trial Management Committee arranged for a technical audit of 76 cases from 11 institutions, conducted by investigators from interstate institutions. A 10% unacceptable protocol violation rate was detected, which compares favourably with initial Radiation Therapy Oncology Group (RTOG) experience in the late 1970s. Infrastructural deficits with poor quality of documentation, incomplete retrieval of films and document return have been demonstrated in some cases. The Trans‐Tasman Radiation Oncology Group is actively pursuing procedural and resourcing issues in order to redress this and is actively expanding its Quality Assurance (QA) Programme with an intercentre dosimetry study. Ultimately, comprehensive clinical and technical QA site visits are planned.
- 1 May 1999
- Published by Wiley in Australasian Radiology
- Vol. 43 (2) , 227-232
Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01)
The Trans‐Tasman Radiation Oncology Group (TROG) initiated a randomized trial, testing accelerated (twice daily) radiotherapy against conventional radiotherapy for stage III and stage IV squamous cell carcinoma of the head and neck in 1991. In 1996, the Trial Management Committee arranged for a technical audit of 76 cases from 11 institutions, conducted by investigators from interstate institutions. A 10% unacceptable protocol violation rate was detected, which compares favourably with initial Radiation Therapy Oncology Group (RTOG) experience in the late 1970s. Infrastructural deficits with poor quality of documentation, incomplete retrieval of films and document return have been demonstrated in some cases. The Trans‐Tasman Radiation Oncology Group is actively pursuing procedural and resourcing issues in order to redress this and is actively expanding its Quality Assurance (QA) Programme with an intercentre dosimetry study. Ultimately, comprehensive clinical and technical QA site visits are planned.
- 1 January 1998
- Published by Wiley in Medical Journal of Australia
- Vol. 168 (1) , 28-30
Expanding the evidence base for localised prostate cancer
Australasia is ideally placed to conduct the world's first adequate trial of definitive radiation therapy for localised prostate cancer
- 1 January 1998
- Published by Wiley in Medical Journal of Australia
- Vol. 168 (1) , 28-30
Expanding the evidence base for localised prostate cancer
Australasia is ideally placed to conduct the world's first adequate trial of definitive radiation therapy for localised prostate cancer